The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Open accessAbstract
Recently targeted disruption of Omi/HtrA2 has been found to cause neurodegeneration and a parkinsonian phenotype in mice. Using a candidate gene approach, we performed a mutation screening of the Omi/HtrA2 gene in German Parkinson's disease (PD) patients. In four patients, we identified a novel heterozygous G399S mutation, which was absent in healthy controls. Moreover, we identified a novel A141S polymorphism that was associated with PD (P<0.05). Both mutations resulted in defective activation of the protease activity of Omi/HtrA2. Immunohistochemistry and functional analysis in stably transfected cells revealed that S399 mutant Omi/HtrA2 and to a lesser extent, the risk allele of the A141S polymorphism induced mitochondrial dysfunction associated with altered mitochondrial morphology. Cells overexpressing S399 mutant Omi/HtrA2 were more susceptible to stress-induced cell death than wild-type. On the basis of functional genomics, our results provide a novel link between mitochondrial dysfunction and neurodegeneration in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GENEPOP (Version 1.2): Population Genetics Software for Exact Tests and Ecumenicism
Raymond, M., & Rousset, F. (1995) · Journal of Heredity · doi:10.1093/oxfordjournals.jhered.a111573 · Cited by 15,397
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“as seen in parkin, PINK1 and DJ-1 mutations defining PARK2, PARK6 and PARK7, respectively (25,26,28).”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., & Takahashi, R. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00341-0 · Cited by 1,116
Hegde, R., Srinivasula, S. M., Zhang, Z., Wassell, R., Mukattash, R., Cilenti, L., DuBois, G., Lazebnik, Y., Zervos, A. S., Fernandes-Alnemri, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109721200 · Cited by 745
Cordell, H. J., & Clayton, D. G. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67424-7 · Cited by 582
Verhagen, A. M., Silke, J., Ekert, P. G., Pakusch, M., Kaufmann, H., Connolly, L. M., Day, C. L., Tikoo, A., Burke, R., Wrobel, C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109891200 · Cited by 559
The Serine Protease Omi/HtrA2 Regulates Apoptosis by Binding XIAP through a Reaper-like Motif
Martins, L. M., Iaccarino, I., Tenev, T., Gschmeissner, S., Totty, N. F., Lemoine, N. R., Savopoulos, J., Gray, C. W., Creasy, C. L., Dingwall, C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109784200 · Cited by 542
Self-citationWalsh, N. P., Alba, B. M., Bose, B., Gross, C. A., & Sauer, R. T. (2003) · Cell · doi:10.1016/s0092-8674(03)00203-4 · Cited by 508
Energetics in the pathogenesis of neurodegenerative diseases
Beal, M. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01584-8 · Cited by 474
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Gasser, T., Müller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P., & Horstmann, R. D. (1998) · Nature Genetics · doi:10.1038/ng0398-262 · Cited by 458
Self-citationDJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism
Bonifati, V., Rizzu, P., Squitieri, F., Krieger, E., Vanacore, N., van Swieten, J. C., Brice, A., van Duijn, C. M., Oostra, B., Meco, G., et al. (2003) · Neurological Sciences · doi:10.1007/s10072-003-0108-0 · Cited by 427
Martins, L. M., Morrison, A., Klupsch, K., Fedele, V., Moisoi, N., Teismann, P., Abuin, A., Grau, E., Geppert, M., Livi, G. P., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9848-9862.2004 · Cited by 394
Self-citationNeuronal degeneration and mitochondrial dysfunction
Schon, E. A., & Manfredi, G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17741 · Cited by 392
Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice
Jones, J. M., Datta, P., Srinivasula, S. M., Ji, W., Gupta, S., Zhang, Z., Davies, E., Hajnóczky, G., Saunders, T. L., Van Keuren, M. L., et al. (2003) · Nature · doi:10.1038/nature02052 · Cited by 377
Schapira, A. H. V. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00164-9 · Cited by 310
Crystal Structure of the DegS Stress Sensor
Wilken, C., Kitzing, K., Kurzbauer, R., Ehrmann, M., & Clausen, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00454-4 · Cited by 285
Gray, C. W., Ward, R. V., Karran, E., Turconi, S., Rowles, A., Viglienghi, D., Southan, C., Barton, A., Fantom, K. G., West, A., et al. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01589.x · Cited by 278
Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi
Li, W., Srinivasula, S. M., Chai, J., Li, P., Wu, J.-W., Zhang, Z., Alnemri, E. S., & Shi, Y. (2002) · Nature Structural Biology · doi:10.1038/nsb795 · Cited by 276
A susceptibility gene for late‐onset idiopathic Parkinson's disease
Hicks, A. A., Pétursson, H., Jónsson, T., Stefánsson, H., Jóhannsdóttir, H. S., Sainz, J., Frigge, M. L., Kong, A., Gulcher, J. R., Stefánsson, K., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10324 · Cited by 260
Sawada, R., Lowe, J. B., & Fukuda, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31441-8 · Cited by 130
Binding Specificity and Regulation of the Serine Protease and PDZ Domains of HtrA2/Omi*
Martins, L. M., Turk, B., Cowling, V., Borg, A., Jarrell, E. T., Cantley, L., & Downward, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308659200 · Cited by 129
Self-citationBird, T. D., Jarvik, G. P., & Wood, N. W. (2001) · Neurology · doi:10.1212/wnl.57.7.1153 · Cited by 103
The C-terminal Tail of Presenilin Regulates Omi/HtrA2 Protease Activity
Gupta, S., Singh, R., Datta, P., Zhang, Z., Orr, C. R., Lu, Z., DuBois, G. C., Zervos, A. S., Meisler, M. H., Srinivasula, S. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404940200 · Cited by 99
PARK3 Influences Age at Onset in Parkinson Disease: A Genome Scan in the GenePD Study
DeStefano, A. L., Lew, M., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Guttman, M., Montgomery, E. B., Waters, C., Singer, C., Watts, R. L., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/339814 · Cited by 90
Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi
Park, H., Seong, Y.-M., Choi, J.-Y., Kang, S., & Rhim, H. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.11.068 · Cited by 75
Immunoreactivity of neuronal lipofuscin with monoclonal antibodies to the amyloid β-protein
Bancher, C., Grundke, I., Iqbal, K., Kim, K. S., & Wisniewski, H. M. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90021-3 · Cited by 67
A haplotype at the PARK3 locus influences onset age for Parkinson’s disease: The Gene PD study
Karamohamed, S., DeStefano, A. L., Wilk, J. B., Shoemaker, C. M., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Suchowersky, O., Labelle, N., Guttman, M., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000095966.99430.f4 · Cited by 56
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes
West, A. B., Zimprich, A. A., Lockhart, P. J., Farrer, M. J., Singleton, A., Holtom, B., Lincoln, S., Hofer, A., Hill, L. D., Müller-Myhsok, B., et al. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200698 · Cited by 51
Self-citationGenes influencing Parkinson disease onset
Pankratz, N., Uniacke, S. K., Halter, C. A., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000123112.51368.10 · Cited by 37
Rathke‐Hartlieb, S., Schlomann, U., Heimann, P., Meisler, M. H., Jockusch, H., & Bartsch, J. W. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7868 · Cited by 34
Cited by
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
“The gene most recently associated with PD is HTRA2 (also known as OMI”
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Pathological roles of MAPK signaling pathways in human diseases
Kim, E. K., & Choi, E.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.12.009 · Cited by 2,472
Genetics of Parkinson's Disease
Klein, C., & Westenberger, A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008888 · Cited by 1,358
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Metadata
- Authors
- Strauss, K. M., Martins, L. M., Plun-Favreau, H., Marx, F. P., Kautzmann, S., Berg, D., Gasser, T., Wszolek, Z., Müller, T., Bornemann, A., Wolburg, H., Downward, J., Riess, O., Schulz, J. B., & Krüger, R.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-16
- Volume
- 14
- Issue
- 15
- Pages
- 2099-2111
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2126549314
- Cited by
- 568
- References
- 31
- FWCI
- 21.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.